Free Trial

Aptevo Therapeutics (APVO) Short Interest Ratio & Short Volume

Aptevo Therapeutics logo
$0.53 -0.04 (-6.36%)
As of 04/30/2025 04:00 PM Eastern

Aptevo Therapeutics Short Interest Data

Aptevo Therapeutics (APVO) has a short interest of 703,600 shares, representing 23.30% of the float (the number of shares available for trading by the public). This marks a 82.04% increase in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 850,480 shares to cover all short positions.

Current Short Interest
703,600 shares
Previous Short Interest
386,500 shares
Change Vs. Previous Month
+82.04%
Dollar Volume Sold Short
$675,456.00
Short Interest Ratio
0.3 Days to Cover
Last Record Date
April 15, 2025
Outstanding Shares
1,459,000 shares
Float Size
3,020,000 shares
Short Percent of Float
23.30%
Today's Trading Volume
926,975 shares
Average Trading Volume
850,480 shares
Today's Volume Vs. Average
109%
Short Selling Aptevo Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Aptevo Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

APVO Short Interest Over Time

APVO Days to Cover Over Time

APVO Percentage of Float Shorted Over Time

Aptevo Therapeutics Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/15/2025703,600 shares $675,456.00 +82.0%23.3%0.3 $0.96
3/31/2025386,500 shares $448,340.00 +220.5%12.0%0.2 $1.16
3/15/2025120,600 shares $290,646.00 +100.7%8.3%1.8 $2.41
2/28/202560,100 shares $229,582.00 +155.7%4.1%0.3 $3.82
2/15/202523,500 shares $78,490.00 -46.2%1.6%0.1 $3.34
1/31/202543,700 shares $191,406.00 +64.9%3.0%0.2 $4.38
1/15/202526,500 shares $120,575.00 +39.5%1.8%0.1 $4.55
12/31/202419,000 shares $81,890.00 -92.1%1.3%0.1 $4.31
12/15/2024241,700 shares $988,553.00 +536.1%16.6%0.8 $4.09
11/30/202438,000 shares $14.57 million -94.8%7.6%0.2 $383.32
11/15/2024734,600 shares $155,000.60 -38.8%N/A0.1 $0.21
10/31/20241,200,000 shares $323,880.00 +675.7%N/A0.2 $0.27
10/15/2024154,700 shares $22,416.03 +164.9%N/A0 $0.14
9/30/202458,400 shares $10,500.32 +349.2%N/A0 $0.18
9/15/202413,000 shares $4,613.70 -78.8%N/A0 $0.35
8/31/202461,400 shares $22,104.00 -80.2%N/A0 $0.36
8/15/2024310,700 shares $135,154.50 -54.8%N/A0.1 $0.44
7/31/2024687,500 shares $277,268.75 +2.9%N/A0.1 $0.40
7/15/2024668,300 shares $203,965.16 +91.7%N/A0.1 $0.31
6/30/2024348,700 shares $106,702.20 +1,552.6%N/A0.4 $0.31
6/15/202421,100 shares $16,198.47 -55.8%0.5%0 $0.77
5/31/202447,700 shares $33,991.02 -11.7%1.2%0.1 $0.71
5/15/202454,000 shares $43,632.00 -79.9%1.3%0.1 $0.81
4/30/2024268,200 shares $190,609.74 +84.2%16.8%0.3 $0.71
4/15/2024145,600 shares $114,004.80 +324.5%9.1%0.6 $0.78
3/31/202434,300 shares $160,867.00 +18.7%5.1%0.3 $4.69
3/15/202428,900 shares $156,638.00 +725.7%5.5%0.3 $5.42
2/29/20243,500 shares $26,180.00 -82.1%N/A0 $7.48
2/15/202419,600 shares $3,077.20 +17.4%N/A0.1 $0.16
1/31/202416,700 shares $2,715.42 -78.8%N/A0 $0.16
1/15/202478,900 shares $12,545.10 -61.3%N/A0.2 $0.16
12/31/2023203,900 shares $36,905.90 +253.4%N/A0.3 $0.18
12/15/202357,700 shares $9,924.40 -46.0%N/A0.1 $0.17
11/30/2023106,800 shares $19,971.60 +297.0%N/A0.2 $0.19
11/15/202326,900 shares $4,976.50 -74.2%N/A0.1 $0.19
10/31/2023104,300 shares $29,485.61 -19.3%N/A0.2 $0.28
10/15/2023129,200 shares $41,344.00 +7.4%N/A0.3 $0.32
9/30/2023120,300 shares $39,699.00 +161.5%N/A0.4 $0.33
9/15/202346,000 shares $18,446.00 -46.6%N/A0.1 $0.40
8/31/202386,200 shares $37,928.00 +176.3%N/A0.3 $0.44
Donald Trump is about to free crypto from its chains … (Ad)

Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.

There's another coin he thinks could do even better.
8/15/202331,200 shares $11,544.00 -97.8%N/A0.1 $0.37
7/31/20231,390,000 shares $1.45 million +3,837.7%N/A5.6 $1.04
7/15/202335,300 shares $52,950.00 +13.1%N/A0.2 $1.50
6/30/202331,200 shares $45,552.00 +51.5%N/A0.6 $1.46
6/15/202320,600 shares $32,960.00 -59.7%N/A0.4 $1.60
5/31/202351,100 shares $79,716.00 -28.0%N/A1 $1.56
5/15/202371,000 shares $117,150.00 -47.6%N/A1.3 $1.65
4/30/2023135,500 shares $260,160.00 +47.8%N/A2.4 $1.92
4/15/202391,700 shares $174,230.00 -35.1%N/A1.6 $1.90
3/31/2023141,200 shares $287,342.00 +34.2%N/A2 $2.04
3/15/2023105,200 shares $190,412.00 -30.1%N/A1.2 $1.81
2/28/2023150,400 shares $318,848.00 +118.6%N/A0.2 $2.12
2/15/202368,800 shares $141,040.00 -49.1%N/A0.1 $2.05
1/31/2023135,100 shares $310,730.00 -27.3%N/A0.2 $2.30
1/15/2023185,800 shares $418,050.00 -32.3%N/A0.2 $2.25
12/30/2022274,500 shares $636,840.00 -38.8%N/A0.4 $2.32
12/15/2022448,700 shares $1.01 million +764.6%N/A0.6 $2.25
11/30/202251,900 shares $161,928.00 -2.8%N/A1.5 $3.12
11/15/202253,400 shares $178,890.00 -12.3%N/A1.5 $3.35
10/31/202260,900 shares $183,918.00 +6.8%N/A1.3 $3.02
10/15/202257,000 shares $161,310.00 +8.6%N/A0.9 $2.83
9/30/202252,500 shares $159,600.00 +23.8%N/A0.9 $3.04
9/15/202242,400 shares $158,576.00 +3.9%N/A0.7 $3.74
8/31/202240,800 shares $144,432.00 -4.5%N/A0.4 $3.54
8/15/202242,700 shares $195,993.00 -48.9%N/A0.5 $4.59
7/31/202283,500 shares $328,990.00 -9.3%N/A1 $3.94
7/15/202292,100 shares $361,032.00 -30.2%N/A1.3 $3.92
6/30/2022132,000 shares $472,560.00 -24.8%N/A1.4 $3.58
6/15/2022175,600 shares $579,480.00 +20.9%N/A0.8 $3.30
5/31/2022145,200 shares $665,016.00 +1.0%N/A0.7 $4.58
5/15/2022143,700 shares $661,020.00 -13.4%N/A0.7 $4.60
4/30/2022165,900 shares $706,734.00 -12.2%N/A0.7 $4.26
4/15/2022188,900 shares $899,164.00 -6.3%N/A0.7 $4.76
3/31/2022201,600 shares $1.18 million +39.5%N/A0.8 $5.87
3/15/2022144,500 shares $647,360.00 +1.4%N/A1 $4.48
2/28/2022142,500 shares $820,800.00 -19.4%N/A0.6 $5.76
2/15/2022176,800 shares $1.11 million +247.4%N/A0.1 $6.29
1/31/202250,900 shares $297,256.00 -65.8%N/A0 $5.84
1/15/2022148,600 shares $1.07 million -35.3%N/A0 $7.22
12/31/2021229,500 shares $1.81 million -25.8%N/A0.1 $7.87
12/15/2021309,400 shares $2.44 million -72.4%N/A0.1 $7.90
11/30/20211,120,000 shares $11.16 million +1,182.9%N/A0.3 $9.96
11/15/202187,300 shares $848,556.00 +4.9%N/A0 $9.72
10/29/202183,200 shares $1.27 million +32.3%N/A1.6 $15.24
10/15/202162,900 shares $942,871.00 +4.7%N/A1.4 $14.99
9/30/202160,100 shares $927,944.00 -6.1%N/A1.2 $15.44
9/15/202164,000 shares $1.10 million -13.9%N/A1.2 $17.14
8/31/202174,300 shares $1.33 million -20.8%N/A1 $17.95
8/13/202193,800 shares $1.59 million -1.7%N/A1.2 $17.00
7/30/202195,400 shares $1.79 million -9.2%2.3%1.3 $18.77
Donald Trump is about to free crypto from its chains … (Ad)

Sure enough, Bitcoin took off on the exact day Juan said it would. It's up more than 40% since the election … surpassing $100,000 on Dec. 8 .… Now Juan believes it could hit $150,000 … or higher in 2025.

There's another coin he thinks could do even better.
7/15/2021105,100 shares $1.87 million -5.0%2.5%1.4 $17.75
6/30/2021110,600 shares $2.48 million +5.2%2.7%1.5 $22.43
6/15/2021105,100 shares $3.15 million -10.0%2.5%1.6 $30.00
5/28/2021116,800 shares $3.05 million +15.3%2.8%2.5 $26.12
5/14/2021101,300 shares $2.22 million -24.7%2.4%2.5 $21.93
4/30/2021134,600 shares $3.68 million +1.4%3.2%2.9 $27.34
4/15/2021132,800 shares $3.40 million -9.8%3.3%2.5 $25.57
3/31/2021147,300 shares $4.15 million -19.8%3.6%2.3 $28.20
3/15/2021183,600 shares $6.60 million -8.4%4.6%2.6 $35.97
2/26/2021200,500 shares $6.34 million +21.0%5.0%2.6 $31.62
2/12/2021165,700 shares $6.09 million +19.1%4.1%1.7 $36.76
1/29/2021139,100 shares $4.84 million +11.0%3.5%0.2 $34.83
1/15/2021125,300 shares $4.24 million -18.1%3.1%0.1 $33.82
12/31/2020153,000 shares $5.68 million -7.7%3.8%0.1 $37.11
12/15/2020165,800 shares $6.90 million -40.1%4.2%0.1 $41.61
11/30/2020276,700 shares $12.28 million -71.0%7.5%0.2 $44.39
11/15/2020955,400 shares $42.97 million +999.4%25.9%0.6 $44.98
10/30/202086,900 shares $572,671.00 +2.4%3.0%0.1 $6.59
10/15/202084,900 shares $594,300.00 -15.1%3.0%1.6 $7.00
9/30/2020100,000 shares $760,000.00 +33.7%3.5%1.2 $7.60
9/15/202074,800 shares $596,156.00 +9.2%2.6%0.1 $7.97
8/31/202068,500 shares $537,040.00 -20.3%2.4%0.1 $7.84
8/14/202085,900 shares $684,623.00 +39.7%3.0%0.1 $7.97
7/31/202061,500 shares $516,600.00 +27.6%2.1%0.1 $8.40
7/15/202048,200 shares $352,342.00 -75.1%1.7%0.1 $7.31
6/30/2020193,600 shares $1.62 million +147.6%6.7%0.3 $8.35
6/15/202078,200 shares $420,716.00 -0.4%2.7%0.8 $5.38
5/29/202078,500 shares $466,290.00 -3.8%2.7%0.6 $5.94
5/15/202081,600 shares $446,352.00 +54.0%2.8%0.6 $5.47

APVO Short Interest - Frequently Asked Questions

What is Aptevo Therapeutics' current short interest?

Short interest is the volume of Aptevo Therapeutics shares that have been sold short but have not yet been covered or closed out. As of April 15th, investors have sold 703,600 shares of APVO short. 23.30% of Aptevo Therapeutics' shares are currently sold short. Learn More on Aptevo Therapeutics' current short interest.

Which institutional investors are shorting Aptevo Therapeutics?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Aptevo Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

What is a good short interest percentage for Aptevo Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 23.30% of Aptevo Therapeutics' floating shares are currently sold short.

Is Aptevo Therapeutics' short interest increasing or decreasing?

Aptevo Therapeutics saw a increase in short interest in the month of April. As of April 15th, there was short interest totaling 703,600 shares, an increase of 82.0% from the previous total of 386,500 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Aptevo Therapeutics' float size?

Aptevo Therapeutics currently has issued a total of 1,459,000 shares. Some of Aptevo Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Aptevo Therapeutics currently has a public float of 3,020,000 shares.

How does Aptevo Therapeutics' short interest compare to its competitors?

23.30% of Aptevo Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Aptevo Therapeutics: Conduit Pharmaceuticals Inc. (222.54%), Sonoma Pharmaceuticals, Inc. (3.31%), InMed Pharmaceuticals Inc. (6.12%), Onconetix, Inc. (3.45%), Sunshine Biopharma, Inc. (3.78%), Evoke Pharma, Inc. (1.84%), Titan Pharmaceuticals, Inc. (1.11%), Creative Medical Technology Holdings, Inc. (2.57%), Genetic Technologies Limited (0.59%), Artelo Biosciences, Inc. (26.92%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

What does it mean to sell short Aptevo Therapeutics stock?

Short selling APVO is an investing strategy that aims to generate trading profit from Aptevo Therapeutics as its price is falling. APVO shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Aptevo Therapeutics?

A short squeeze for Aptevo Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of APVO, which in turn drives the price of the stock up even further.

How often is Aptevo Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including APVO, twice per month. The most recent reporting period available is April, 15 2025.




This page (NASDAQ:APVO) was last updated on 5/1/2025 by MarketBeat.com Staff
From Our Partners